EUVIMEDEUVIMED entdecken
Crossref

Niclosamide modulates cyclosporin A-induced hepatotoxicity in a mouse model: PPAR-γ and Wnt/β-catenin crosstalk

Safaa A Faheem, Reem M Hazem, Norhan M Elsayed, Yasser M Ahmed, Noha M Saeed

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.109941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Safaa A Faheem und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Niclosamide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: The aim of this study was to evaluate whether: 1) Wnt/β-catenin signaling is involved in cyclosporin A (CsA)-induced hepatotoxicity, and 2) knockdown of this pathway by niclosamide (NCL) attenuate CsA-induced hepatotoxicity. METHODS: The experiment was accomplished in 21 days. Adult male mice were randomly distributed into five groups: control group, CsA (25 mg/kg/day) group, CsA + NCL (2.5 mg/kg/day) group, CsA + NCL (5 mg/kg/day) group, and NCL (5 mg/kg/day) group. RESULTS: NCL showed marked hepatoprotection by significantly decreasing liver enzymes activities and ameliorating the histopathological alterations induced by CsA. Besides, NCL alleviated oxidative stress and inflammation. NCL-treated groups (2.5 and 5 mg/kg) displayed rise in the expression of hepatic peroxisome proliferator-activated receptor-γ (PPAR-γ) by 2.1- and 2.5-fold, respectively. Notably, NCL (2.5 and 5 mg/kg) significantly inhibited Wnt/β-catenin signaling, evidenced by a marked decrease in the hepatic expression of Wnt3a by 54 % and 50 %, frizzled-7 receptor by 50 % and 50 %, β-catenin by 22 % and 49 %, and c-myc by 50 % and 50 %, respectively. CONCLUSIONS: NCL can be regarded as a potential agent to mitigate CsA-induced hepatotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical and Drug Induced Liver InjuryNiclosamideAnimalsMaleMicebeta CateninCyclosporinePPAR gammaWnt Signaling Pathway

Stichwörter der Autor:innen

Frizzled receptorHepatotoxicityNiclosamidePPAR-γWnt/β-cateninWnt3a

Substanzen

beta CateninCyclosporineNiclosamidePPAR gamma

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Badr University in Cairo, Cairo, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt. Electronic address: noha_msaeed@eru.edu.eg.

Zitieren

APA

Faheem, S. A., Hazem, R. M., Elsayed, N. M., Ahmed, Y. M., & Saeed, N. M. (2023). Niclosamide modulates cyclosporin A-induced hepatotoxicity in a mouse model: PPAR-γ and Wnt/β-catenin crosstalk. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.109941

Vancouver

Faheem SA, Hazem RM, Elsayed NM, Ahmed YM, Saeed NM. Niclosamide modulates cyclosporin A-induced hepatotoxicity in a mouse model: PPAR-γ and Wnt/β-catenin crosstalk. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.109941

BibTeX
@article{Faheem2023,
  author = {Faheem, Safaa A and Hazem, Reem M and Elsayed, Norhan M and Ahmed, Yasser M and Saeed, Noha M},
  title = {Niclosamide modulates cyclosporin A-induced hepatotoxicity in a mouse model: PPAR-γ and Wnt/β-catenin crosstalk},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.109941}
}
Kostenlos starten →